Evidence map›Paper›PMID 34943675›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Isolation of Human Lineage, Fluoroquinolone-Resistant and Extended-β-Lactamase-Producing

Toyotaka Sato, Shin-Ichi Yokota, Tooru Tachibana, Satoshi Tamai, Shigeki Maetani, Yutaka Tamura, Motohiro Horiuchi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Prevalence of antimicrobial-resistantOne health (Amsterdam, Netherlands) · 2026
    Article
  2. A community-based One Health approach to the pandemic dynamics ofAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Traces of pandemic fluoroquinolone-resistantOne health (Amsterdam, Netherlands) · 2024
    Article
  5. One health transmission of fluoroquinolone-resistantOne health (Amsterdam, Netherlands) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Toyotaka SatoLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Shin-Ichi YokotaDepartment of Microbiology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.ORCID 0000-0002-0831-3429
Tooru TachibanaHokko Animal Hospital, Sapporo 065-0014, Japan.
Satoshi TamaiTamai Animal Hospital, Sapporo 062-0034, Japan.
Shigeki MaetaniMaetani Animal Hospital, Sapporo 002-8003, Japan.
Yutaka TamuraSchool of Veterinary Medicine, Rakuno Gakuen University, Professor Emeritus, Ebetsu 069-8501, Japan.
Motohiro HoriuchiLaboratory of Veterinary Hygiene, Faculty of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Sapporo Medical University · JPFujita Animal Hospital · JPHokkaido University · JPHokko Memorial Hospital · JPRakuno Gakuen University · JP

Funding

Japan Agency for Medical Research and Development JP20ak0101118h0002Japan Society for the Promotion of Science JP20H03488Japan Society for the Promotion of Science JP21H03622
6 · The paper itself

Abstract

An increase in human and veterinary fluoroquinolone-resistant

Indexed as

catsdogsESBLEscherichia colifluoroquinolone-resistance

Identifiers

PMID34943675
PMCPMC8698614
OpenAlexW3217473761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.